Neurol. praxi. 2013;14(3):133-135

Evaluation of quality of life for selected neurological diseases

doc.MUDr.Eva Vaňásková, Ph.D., MUDr.Michal Bednář
Rehabilitační klinika, LF UK a FN Hradec Králové

The use of rating scales has been more and more common in the rehabilitation facilities. Not only specific tests are available for particular

diagnoses containing a description of impairment, with a long tradition of use at our departments, but now also tests describing activities,

participation, and quality of life of patients. For the purpose of neurorehabilitation, the authors comment on the tests for stroke,

multiple sclerosis, and Parkinson’s disease.

Keywords: testing, quality of life, stroke, multiple sclerosis, Parkinson´s disease

Published: September 23, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vaňásková E, Bednář M. Evaluation of quality of life for selected neurological diseases. Neurol. praxi. 2013;14(3):133-135.
Download citation

References

  1. Bolton BF, Parker RM. Handbook of Measurement and Evaluation in Rehabilitation. Austin: PRO-ED 2007: 616 s.
  2. Buck D, Jacoby A, Massey A, Ford G. Evaluation of Measures Used to Assess Quality of Life After Stroke. Stroke 2000; 31: 2004-2010. Go to original source... Go to PubMed...
  3. Burks JS, Johnson KP. Multiple sclerosis. New York: Demos 2000: 377 s.
  4. Domholdt E. Rehabilitation Research. St. Louis: Elsevier Saunders 2005: 576 s.
  5. Dragomirecká E, Bartoňová J. WHOQOL-BREF, WHOQOL - 100. Health Organization Quality of Life Assessment. Příručka pro uživatele české verze dotazníků kvality života Světové zdravotnické organizace. 1. vyd. Praha: Psychiatrické centrum. 2006.
  6. Granger CV, Greer DS. Functional Status Measurement and Medical Rehabilitation Outcomes. Arch Phys Med Rehabil 1976; 57: 103-109.
  7. Gurková E. Hodnocení kvality života. 1. vydání, Praha: Grada 2011: 223 s.
  8. Klener P, et al. Vnitřní lékařství. 3. vydání, Praha: Galén 2006: 1158 s.
  9. Mareš J. Význam časné diagnostiky a terapie v životní perspektivě pacientů s roztroušenou sklerózou. Neurol. praxi 2012; 13(5): 270-274.
  10. Mitchel AJ, Benito-León J, Gonzáles JMM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurology 2005; 4(9): 556-566. Go to original source... Go to PubMed...
  11. Růžička E, Roth J, Kaňovský P. Parkinsonova nemoc a parkinsonské syndromy. Extrapyramidová onemocnění I. Praha: Galén 2000: 280 s.
  12. Schrag A, Jahanshahi M, Quinn N. What contributed to quality of life in patients with Parkinson´s disease? J Neurol Neurosurg Psychiatry 2000; 69: 308-312. Go to original source... Go to PubMed...
  13. Slováček L, Slováčková B, Jebavý L, Blažek M, Kačerovský J. Kvalita života nemocných - jeden z důležitých parametrů komplexního hodnocení léčby. Vojenské zdravotnické listy 2004; 123(1): 6-9.
  14. Tan JC. Practical Manual od Physical Medicine and Rehabilitation. New York: Mosby 1998: 161 s.
  15. Vaňásková E. Testování v rehabilitační praxi - cévní mozkové příhody. Skripta. NCO NZO v Brně, 2004: 65 s.
  16. Vaňásková E. Testování v neurorehabilitaci. Neurol. praxi 2005; 6: 311-314.
  17. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Medical Care 1992? 30(6): 473-483. Go to original source... Go to PubMed...
  18. Young T, de Haes H, Curran D, Fayers P, Brandberg Y. Guidelines for Assesing Quality of Life in EORTC Clinical Trials. EORTC quality of life study group. Brussels. 1999.
  19. internetové odkazy.
  20. http://www.qualitymetric.com [cit. 2012-10-10].
  21. http://www.dph.ox.ac.uk/research/hsru/PDQ/translations.
  22. http://www.epda.eu.com/cs/parkinsons.
  23. http://www.iscare.cz/upl/files/f20b32abff5b75dotaznIk_sf36.doc.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.